Pfizer: Covid vaccine in successful trials on children aged 12-15

Pfizer has applied to the US Food and Drug Authority for emergency use of its covid-19 vaccine on children aged 12-15 after successful trials on a sample group of 2,260. The company expects approval within weeks. Without waiting for FDA approval, Israel has begun inoculating high-risk children in that age group, vaccinating altogether 650 who suffered from background ailments.

Print Friendly, PDF & Email
Font Resize
Contrast